ClinicalTrials.gg
CompletedNCT07034235Updated Jun 24, 2025

Effect of Wet and Overwet Dentin on the Clinical Performance of Two Universal Adhesive Systems

An interventional study of Dentin Wet and Dentin Overwet in Non-carious Cervical Lesions, sponsored by Universidad de los Andes, Chile. Completed at 1 site in Chile. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by Universidad de los Andes, Chile · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2025, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The aim of this study will be to evaluate the effect of wet and overwet dentin on the long-term clinical performance of two universal adhesive systems used as etch-and-rinse application mode in non-carious cervical lesions (NCCLs).

Materials \& Methods: 200 restorations will be randomly placed in 50 subjects according to the following groups (n=50): AMP-wet (Ambar Universal APS Plus adhesive on wet dentin); AMP-overwet (Ambar Universal APS Plus adhesive on oversaturated dentin); PBA-wet (Prime\&Bond Active adhesive on wet dentin); PBA-overwet (Prime\&Bond Active adhesive on oversaturated dentin). For all groups, the enamel and dentin will be etched for 15s. All groups will be light-cured for 10s/1,000 mW/cm2. A resin composite will be placed by applying three increments and each one was light cured for 20s/1,000 mW/cm2. The restorations will be finished immediately with fine diamond burs and spiral polishers. The restorations will be evaluated at baseline and after 6 months by using the FDI criteria. The following outcomes will be evaluated: retention, marginal staining, marginal adaptation, post-operative sensitivity and recurrence of caries. The differences among the groups will be calculated using Friedman repeated measures analysis of variance rank (α = 0.05).

Read the detailed description

This is a four-arm, double-blind, randomized controlled clinical trial.

Control group 1: 50 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on wet dentin in the etch-and-rinse application strategy.

Control group 2: 50 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Prime\&Bond Active; Dentsply Sirona) on wet dentin in the etch-and-rinse application strategy.

Experimental group 1: 50 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on overwet dentin in the etch-and-rinse application strategy.

Experimental group 2: 50 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Prime\&Bond Active; Dentsply Sirona) on overwet dentin in the etch-and-rinse application strategy

LCNCs will be randomized to universal adhesive usage and dentinal moisture levels. All groups will be light-cured with a lightcuring device (Quazar, FGM) with a light intensity of 900 mW/cm² for 10 seconds. Operators will restore the cervical area by applying three increments of resin (Llis-FGM for experimental groups 1 and 2; and TPH Spectrum-Dentsply for experimental groups 3 and 4). Each increment will light cure for 20 s at 900 mW/cm2 (Quazar, FGM). Restorations will be finished immediately with fine and extra fine diamond burs and polished with polishing spirals.

02

Conditions studied

  • Non-carious Cervical Lesions

Keywords

  • Dental bonding
  • Tooth erosion
  • Tooth Wear
  • Adhesive systems
  • Dentinal moisture
03

In context

Tooth Erosion

47 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.

This study's enrollment of 50 is above the median of 33 across 33 interventional studies indexed under Tooth Erosion.

Browse Tooth Erosion studies →

Lead sponsor

Universidad de los Andes, Chile is the lead sponsor of 46 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 18 years.
  • Presence of at least two Non-Carious Cervical Lesions in the dental arch with a need for restorative treatment.
  • Acceptable level of oral hygiene according to the Simplified Oral Hygiene Index.
  • At least 20 teeth in function.

Exclusion criteria

Exclusion Criteria:

  • Driving difficulties that prevent adequate oral hygiene.
  • Periodontal disease.
  • Active caries lesions on the teeth included in the research.
  • Parafunctional habits.
  • Active staples of removable partial dentures on the teeth included in the research and that these are not pillars of prostheses.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Experimental group 1

    50 non-carious cervical lesions (NCCL) will receive composite resin restorations in the etch-and-rinse strategy.

    Procedure: Dentin Overwet · Device: Ambar Universal APS Plus; FGM

  • Experimental
    Experimental group 2

    50 non-carious cervical lesions (NCCL) will receive composite resin restorations in the etch-and-rinse strategy.

    Procedure: Dentin Overwet · Device: Prime&Bond Active; Dentsply Sirona

  • Active comparator
    Control group 1

    50 non-carious cervical lesions (NCCL) will receive composite resin restorations in the etch-and-rinse strategy.

    Procedure: Dentin Wet · Device: Ambar Universal APS Plus; FGM

  • Active comparator
    Control group 2

    50 non-carious cervical lesions (NCCL) will receive composite resin restorations in the etch-and-rinse strategy.

    Procedure: Dentin Wet · Device: Prime&Bond Active; Dentsply Sirona

Interventions

  • ProcedureDentin Wet

    Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on wet dentin in the etch-and-rinse application strategy.

  • ProcedureDentin Overwet

    Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on overwet dentin in the etch-and-rinse application strategy.

  • DeviceAmbar Universal APS Plus; FGM

    Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive

  • DevicePrime&Bond Active; Dentsply Sirona

    Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive

06

What researchers measure

Primary outcomes

  1. Retention of restorations

    Retention measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Restoration retained, no fractures / cracks; * G: Clinically good - Small hairline crack; * SS: Clinically sufficient/satisfactory - Two or more or larger hairline cracks and/or chipping (not affecting the marginal integrity); * US: Clinically unsatisfactory - Chipping fractures which damage marginal quality; bulk fractures with or without partial loss (less than half of the restoration); * PO: Clinically poor - (Partial or complete) loss of restoration, (replacement necessary).

    Time frame: From date of randomization until thirty-six four months

Secondary outcomes

  1. Marginal Adaptation of restorations

    Marginal Adaptation measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Harmonious outline, no gaps, no discoloration; * G: Clinically good - Small marginal fracture removable by polishing; * SS: Clinically sufficient/satisfactory - Several small enamel or dentin fractures; * US: Clinically unsatisfactory - Notable enamel or dentine wall fracture; * PO: Clinically poor - Filling is loose but in situ.

    Time frame: From date of randomization until thirty six months

  2. Marginal Staining of restorations

    Marginal Staining measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - No marginal staining; * G: Clinically good - Minor marginal staining, easily removable by polishing; * SS: Clinically sufficient/satisfactory - Moderate marginal staining, not esthetically unacceptable; * US: Clinically unsatisfactory - Pronounced marginal staining; major intervention necessary for improvement; * PO: Clinically poor - Deep marginal staining not accessible for intervention

    Time frame: From date of randomization until thirty six months

07

Study locations

1 site
  • Mario Felipe Gutiérrez Reyes
    Santiago, Santiago Metropolitan 8360053, Chile
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Mar 2025, 1 month.

Of 20 interventional studies with no phase under Tooth Erosion, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 28. This study's 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2025
First posted
Jun 24, 2025
StartActual
Jan 6, 2025
Primary completionActual
Mar 3, 2025
CompletionActual
Mar 10, 2025
Last update
Jun 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07034235
Lead sponsor
Universidad de los Andes, Chile
Collaborators
Universidade Estadual de Ponta Grossa
Responsible party
Mario Felipe Gutiérrez Reyes (Associate Professor, Universidad de los Andes, Chile) — Principal investigator
First posted
Jun 24, 2025
Start date
Jan 6, 2025
Primary completion
Mar 3, 2025
Completion
Mar 10, 2025
Last update
Jun 24, 2025

Study contacts

Mario Gutierrez, PhD
study director · Universidad de los Andes, Chile

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion